ATLASPDS Biotechnology (PDSB) earnings date: Nov 12, 2026
PDS Biotechnology (PDSB) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, before the open. Analysts expect EPS of -$0.09.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PDSB
| Last price | $1.38 (-4.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.4% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the PDS Biotechnology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
PDS Biotechnology reports on Nov 12, 2026. One email the day before, with ATLAS’s read on PDS Biotechnology. You can switch it off at any time.
Alert me before PDSB reportsFree to start. Creating an account takes under a minute.
Notify me when PDS Biotechnology reports
Track PDSB free Add PDS Biotechnology to a free ATLAS watchlist and see its next report date in one place.
PDSB earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.09 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -0.3% |
| Average move around a report | ±5.3% (last 4) |
| Sector | Healthcare · Biotechnology |
PDS Biotechnology earnings history: last 4 reports
PDS Biotechnology last reported on Aug 13, 2026: EPS of -$0.18 against an estimate of -$0.13 (-38.5% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.13 | -$0.18 | -38.5% | Miss | -4.6% |
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | +2.4% |
| May 12, 2026 | $0.68 | $0.70 | +2.9% | Beat | +2.3% |
| Mar 30, 2026 | -$0.20 | -$0.14 | +30.0% | Beat | +11.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PDSB
See the fair value, the probability range and the earnings history of PDS Biotechnology on its ATLAS page.
PDS Biotechnology (PDSB) stock analysisPlans from €3.99 a month.
PDS Biotechnology earnings: frequently asked questions
When does PDS Biotechnology (PDSB) report earnings?
PDS Biotechnology is scheduled to report on Thursday, November 12, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PDSB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.09 per share (USD). Estimates can change before the report.
How often does PDSB beat earnings estimates?
Of its last 4 reports with a recorded result, PDS Biotechnology beat the EPS estimate 3 times; the average surprise was -0.3%. Past results do not predict the next one.
How much does PDSB move around earnings?
Over its last 4 reports the stock moved an average of 5.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did PDS Biotechnology beat earnings estimates last quarter?
PDS Biotechnology last reported on Aug 13, 2026: EPS of -$0.18 against an estimate of -$0.13 (-38.5% surprise), a miss.
How much does PDSB usually move in a day?
On a normal trading day the ATLAS model puts PDSB’s one-day range at about ±10.4%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer